» Articles » PMID: 30935846

Science in the Heartland: Exploring Determinants of Offering Cancer Clinical Trials in Rural-serving Community Urology Practices

Overview
Journal Urol Oncol
Publisher Elsevier
Date 2019 Apr 3
PMID 30935846
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities.

Methods: We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis.

Results: Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care.

Conclusions: With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.

Citing Articles

Zooming towards Rapid Qualitative Research for Implementation Science.

Vedapudi V, Byrnes M, Skolarus T, Stensland K Health Behav Res. 2024; 7(3).

PMID: 39713566 PMC: 11661829. DOI: 10.4148/2572-1836.1234.


Stem cell therapy: a new hope for stroke and traumatic brain injury recovery and the challenge for rural minorities in South Carolina.

Mohamed G, Lench D, Grewal P, Rosenberg M, Voeks J Front Neurol. 2024; 15:1419867.

PMID: 39184380 PMC: 11342809. DOI: 10.3389/fneur.2024.1419867.


Rural research capacity: a co-created model for research success.

Farris P, Crist R, Miller S, Shannon J Health Res Policy Syst. 2023; 21(1):76.

PMID: 37488533 PMC: 10364434. DOI: 10.1186/s12961-023-01030-5.


Interventions to improve access to clinical trials in urologic oncology.

Hass A, Guzman J, Feuerstein M Can Urol Assoc J. 2022; 17(3):E67-E74.

PMID: 36473478 PMC: 10027356. DOI: 10.5489/cuaj.8011.


Development of a co-designed behaviour change intervention aimed at healthcare professionals recruiting to clinical trials in maternity care.

Hanrahan V, Lawrie L, Duncan E, Biesty L, Gillies K Trials. 2022; 23(1):870.

PMID: 36224619 PMC: 9556136. DOI: 10.1186/s13063-022-06816-6.


References
1.
Williams C, Maher C, Hancock M, McAuley J, Lin C, Latimer J . Recruitment rate for a clinical trial was associated with particular operational procedures and clinician characteristics. J Clin Epidemiol. 2013; 67(2):169-75. DOI: 10.1016/j.jclinepi.2013.08.007. View

2.
Jacobsen P, Wells K, Meade C, Quinn G, Lee J, Fulp W . Effects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial. J Clin Oncol. 2012; 30(20):2516-21. PMC: 4577714. DOI: 10.1200/JCO.2011.39.5186. View

3.
Goldman D, Berry S, McCabe M, Kilgore M, Potosky A, Schoenbaum M . Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA. 2003; 289(22):2970-7. DOI: 10.1001/jama.289.22.2970. View

4.
Winkfield K, Phillips J, Joffe S, Halpern M, Wollins D, Moy B . Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement. J Clin Oncol. 2018; :JCO1801132. DOI: 10.1200/JCO.18.01132. View

5.
Comis R, Miller J, Aldige C, Krebs L, Stoval E . Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2003; 21(5):830-5. DOI: 10.1200/JCO.2003.02.105. View